Skip to main content

Table 1 Patient demographics and outcomes

From: Long-term follow-up outcomes for patients undergoing primary total hip arthroplasty with uncemented versus cemented femoral components: a retrospective observational study with a 5-year minimum follow-up

VariableUTHAa (n = 160)CTHAb (n = 164)p value
Sex, M/F97/6392/720.409*c
Age, years68.61 ± 7.4968.75 ± 7.040.215*d
BMI, kg/m227.11 ± 7.7527.36 ± 8.120.322*d
BMD− 3.59 ± 0.45− 3.64 ± 0.370.176*d
Side, left/right86/7481/830.432*c
Comorbidities, n%0.296*e
 Hypertension33 (20.6)29 (17.7) 
 Diabetes mellitus37 (23.1)38 (23.2) 
 Cardiopathy15 (9.4)17 (10.4) 
 Hypertension and diabetes mellitus22 (13.8)25 (15.2) 
 Pulmonary24 (15.0)26 (15.8) 
 Cerebrovascular accident16 (10.0)20 (12.2) 
 Anaemia11 (6.9)15 (9.1) 
Mechanism of injury, n%0.454*e
 Traffic-related injury35 (21.8)38 (23.1) 
 Injury by falling89 (55.6)96 (58.5) 
 Tamp injury36 (22.6)30 (18.4) 
ASA Index, n%0.609*e
 I45 (28.1)47 (28.6) 
 II76 (47.5)83 (50.6) 
 III39 (24.4)34 (20.8) 
Preoperative HHS57.82 ± 16.4857.64 ± 15.880.231*d
Follow-up period (months)73.16 ± 11.7273.25 ± 13.580.069*d
  1. UTHA uncemented femoral component total hip arthroplasty, CTHA cemented femoral component total hip arthroplasty, HHS Harris hip score, ASA American Society of Anesthesiologists, BMI body mass index, BMD bone mineral density
  2. *No statistically significant values
  3. a,bUncemented or cemented femoral component: Stryker Orthopaedics, Mahwah, NJ, USA; acetabular component: standard-device, Stryker Orthopaedics, Mahwah, NJ, USA
  4. cAnalysed using the chi-square test
  5. dAnalysed using an independent-samples t test
  6. eAnalysed using the Mann-Whitney test